96 related articles for article (PubMed ID: 20144594)
21. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
Harris LN; Yang L; Tang C; Yang D; Lupu R
Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells.
Saeed ME; Abdelgadir H; Sugimoto Y; Khalid HE; Efferth T
J Ethnopharmacol; 2015 Nov; 174():644-58. PubMed ID: 26165828
[TBL] [Abstract][Full Text] [Related]
23. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
Huan-huan C; Li-Li Y; Shang-Bin L
Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.
Efferth T; Benakis A; Romero MR; Tomicic M; Rauh R; Steinbach D; Häfer R; Stamminger T; Oesch F; Kaina B; Marschall M
Free Radic Biol Med; 2004 Oct; 37(7):998-1009. PubMed ID: 15336316
[TBL] [Abstract][Full Text] [Related]
25. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
26. Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.
Michaelis M; Kleinschmidt MC; Barth S; Rothweiler F; Geiler J; Breitling R; Mayer B; Deubzer H; Witt O; Kreuter J; Doerr HW; Cinatl J; Cinatl J
Biochem Pharmacol; 2010 Jan; 79(2):130-6. PubMed ID: 19698702
[TBL] [Abstract][Full Text] [Related]
27. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G
Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579
[TBL] [Abstract][Full Text] [Related]
28. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
29. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
Fan M; Goodwin ME; Birrer MJ; Chambers TC
Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
[TBL] [Abstract][Full Text] [Related]
30. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
31. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC; Kouros-Mehr H; Kohn KW; Maunakea AK; Lababidi S; Roschke A; Stover K; Alexander J; Pantazis P; Miller L; Liu E; Kirsch IR; Urasaki Y; Pommier Y; Weinstein JN
Cancer Res; 2003 Mar; 63(5):1000-11. PubMed ID: 12615715
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D
Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180
[TBL] [Abstract][Full Text] [Related]
34. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate.
Dell'Eva R; Pfeffer U; Vené R; Anfosso L; Forlani A; Albini A; Efferth T
Biochem Pharmacol; 2004 Dec; 68(12):2359-66. PubMed ID: 15548382
[TBL] [Abstract][Full Text] [Related]
36. The anti-malarial artesunate is also active against cancer.
Efferth T; Dunstan H; Sauerbrey A; Miyachi H; Chitambar CR
Int J Oncol; 2001 Apr; 18(4):767-73. PubMed ID: 11251172
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy.
Efferth T
Drug Resist Updat; 2005; 8(1-2):85-97. PubMed ID: 15878303
[TBL] [Abstract][Full Text] [Related]
38. mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.
Efferth T; Olbrich A; Bauer R
Biochem Pharmacol; 2002 Aug; 64(4):617-23. PubMed ID: 12167480
[TBL] [Abstract][Full Text] [Related]
39. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside.
Efferth T
Planta Med; 2007 Apr; 73(4):299-309. PubMed ID: 17354163
[TBL] [Abstract][Full Text] [Related]
40. Molecular determinants of cancer cell sensitivity and resistance towards the sesquiterpene farnesol.
Kuete V; Efferth T
Pharmazie; 2013 Jul; 68(7):608-15. PubMed ID: 23923645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]